Neuropathix, Inc.
NPTX · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $183 | $0 | $0 | $0 |
| % Growth | – | -100% | -27.5% | – |
| Gross Profit | $183 | $0 | $0 | $0 |
| % Margin | 100% | – | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -0% | – | -1,070.2% | 23.4% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -0% | – | -3,622.9% | 538.7% |
| EPS Diluted | -0.046 | -0.075 | -0.064 | 0.014 |
| % Growth | 38.9% | -16.4% | -571.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |